News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
Eight Roads Plans to Sell Investments in 40 CN Tech Firms: Wire
Amid escalating tensions between the US and China, Eight Roads, a venture capital fund backed by Fidelity Investments' Johnson Family, planned to sell its tech assets in China,...
Reset
Send
The window will close in 5 seconds
Eight Roads Plans to Sell Investments in 40 CN Tech Firms: Wire
Close
Recommend
22
Positive
52
Negative
18
 
SHORT SELL
 
STOCK INFO

Amid escalating tensions between the US and China, Eight Roads, a venture capital fund backed by Fidelity Investments' Johnson Family, planned to sell its tech assets in China, Bloomberg quoted sources as saying.

It is reported that Eight Roads, an early investor in China's internet industry, began evaluating the sale of all of its investments in approx. 40 Chinese tech firms earlier this year. The assets are currently being sold at a discount of 60-80%, with an overall valuation of about US$1 billion, including shares in autonomous cars company Pony.ai.

Related NewsG Sachs Lists 'CN Prominent 10', Incl. TENCENT & BABA-W
Eight Roads China has invested in over 100 companies with investment amounts exceeding US$1.1 billion, including BABA-W (09988.HK)  +1.800 (+1.594%)    Short selling $1.40B; Ratio 16.917%   and INNOVENT BIO (01801.HK)  -1.900 (-2.366%)    Short selling $178.81M; Ratio 8.740%   , according to the company's website.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-06-16 16:25.)

AASTOCKS Financial News
Website: www.aastocks.com
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.